Silymarine during maintenance therapy of acute promyelocytic leukemia

The use of peripheral-blood hematopoietic progenitors mobilized with standard-dose chemotherapy plus granulocyte-colony-stimulating factor to support multicyclic dose-intensive chemotherapy for advanced breast-cancer.

Oncology reports·2011

Advanced breast-cancer - a randomized study of different doses of epirubicin associated with fixed doses of cyclophosphamide and 5-Fluorouracil.

Oncology reports·2011

A prospective, controlled, nonrandomized study on prophylactic parenteral dichloromethylene bisphosphonate (clodronate) in multiple-myeloma.

International journal of oncology·2011

Sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following intensified, accelerated CEE (cyclophosphamide, epirubicin, etoposide) chemotherapy in patients with solid tumors.

International journal of oncology·2011

Trend of incidence, subsite distribution and staging of colorectal neoplasms in the 15-year experience of a specialised cancer registry.

Annals of oncology : official journal of the European Society for Medical Oncology·2004

Response to first-line chemotherapy and long-term survival in patients with multiple myeloma: results of the MM87 prospective randomised protocol.

European journal of cancer (Oxford, England : 1990)·2002

Prognostic significance of monotypic plasma cell infiltration of the bone marrow in patients with Waldenström macroglobulinemia.

Haematologica·2026

Impact of maintenance therapy on survival after autologous stem cell transplant for multiple myeloma regardless of response: a global analysis.

Haematologica·2026

Protecting sickle cell care during Ebola outbreaks.

Haematologica·2026

Epstein-Barr virus reactivation and post-transplant lymphoproliferative disease risk deserve a place in the JAK inhibitor toxicity profile. Comment on: "Janus kinase inhibitors as an evolving treatment for lymphomas and immune-mediated complications".

Haematologica·2026

T-cell lymphoma following chimeric antigen receptor-T therapy: a cause for concern?

Haematologica·2026

Epidemiology of respiratory viral infections among hematopoietic cellular therapy and chimeric antigen receptor T-cell therapy recipients in the post COVID-19 era.

Haematologica·2026

Limiting the Parameter Space for Unstable eV-Scale Neutrinos Using IceCube Data.

Physical review letters·2026

The Tandem Reconnection and Cusp Electrodynamics Reconnaissance Satellites (TRACERS) Magnetic Control Plan.

Space science reviews·2026

Pathology of the extrapleural space: Keys to diagnosis.

Radiologia·2026

Realizing Remarkable Energy Storage at the Low Earth Orbit Temperature Range in Ternary (2-x)SrTiO3·x(Bi0.5Na0.5)TiO3·Bi4Ti3O12 Solid Solutions.

Small (Weinheim an der Bergstrasse, Germany)·2026

Induced magnetosphere of Mars responds fast to interplanetary magnetic field rotation.

Nature communications·2026

Nuclear speckles: New insights into structure and function.

Current opinion in structural biology·2026

Related Experiment Videos

Silymarine during maintenance therapy of acute promyelocytic leukemia

Related Concept Videos

The use of peripheral-blood hematopoietic progenitors mobilized with standard-dose chemotherapy plus granulocyte-colony-stimulating factor to support multicyclic dose-intensive chemotherapy for advanced breast-cancer.

Advanced breast-cancer - a randomized study of different doses of epirubicin associated with fixed doses of cyclophosphamide and 5-Fluorouracil.

A prospective, controlled, nonrandomized study on prophylactic parenteral dichloromethylene bisphosphonate (clodronate) in multiple-myeloma.

Sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following intensified, accelerated CEE (cyclophosphamide, epirubicin, etoposide) chemotherapy in patients with solid tumors.

Trend of incidence, subsite distribution and staging of colorectal neoplasms in the 15-year experience of a specialised cancer registry.

Response to first-line chemotherapy and long-term survival in patients with multiple myeloma: results of the MM87 prospective randomised protocol.

Prognostic significance of monotypic plasma cell infiltration of the bone marrow in patients with Waldenström macroglobulinemia.

Impact of maintenance therapy on survival after autologous stem cell transplant for multiple myeloma regardless of response: a global analysis.

Protecting sickle cell care during Ebola outbreaks.

Epstein-Barr virus reactivation and post-transplant lymphoproliferative disease risk deserve a place in the JAK inhibitor toxicity profile. Comment on: "Janus kinase inhibitors as an evolving treatment for lymphomas and immune-mediated complications".

T-cell lymphoma following chimeric antigen receptor-T therapy: a cause for concern?

Epidemiology of respiratory viral infections among hematopoietic cellular therapy and chimeric antigen receptor T-cell therapy recipients in the post COVID-19 era.

Limiting the Parameter Space for Unstable eV-Scale Neutrinos Using IceCube Data.

The Tandem Reconnection and Cusp Electrodynamics Reconnaissance Satellites (TRACERS) Magnetic Control Plan.

Pathology of the extrapleural space: Keys to diagnosis.

Realizing Remarkable Energy Storage at the Low Earth Orbit Temperature Range in Ternary (2-x)SrTiO3·x(Bi0.5Na0.5)TiO3·Bi4Ti3O12 Solid Solutions.

Induced magnetosphere of Mars responds fast to interplanetary magnetic field rotation.

Nuclear speckles: New insights into structure and function.

Related Experiment Videos

Silymarine during maintenance therapy of acute promyelocytic leukemia

Related Concept Videos

Related Articles